Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

Hydroxychloroquine (HCQ) has been largely used and investigated as therapy for COVID-19 across various settings at a total dose usually ranging from 2400 mg to 9600 mg. In Belgium, off-label use of low-dose HCQ (total 2400 mg over 5 days) was recommended for hospitalised patients with COVID-19. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Catteau, Lucy, Dauby, Nicolas, Montourcy, Marion, Bottieau, Emmanuel, Hautekiet, Joris, Goetghebeur, Els, van Ierssel, Sabrina, Duysburgh, Els, Van Oyen, Herman, Wyndham-Thomas, Chloé, Van Beckhoven, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444610/
https://www.ncbi.nlm.nih.gov/pubmed/32853673
http://dx.doi.org/10.1016/j.ijantimicag.2020.106144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444610/
https://www.ncbi.nlm.nih.gov/pubmed/32853673
http://dx.doi.org/10.1016/j.ijantimicag.2020.106144

Ejemplares similares